Evidence map›Paper›PMID 42028250›Full record

ArticleBiophotonics discovery2025

Identification of colorectal malignancies enabled by phasor-based autofluorescence lifetime macroimaging and ensemble learning.

João L Lagarto, Alberto I Herrando, Rafaela Rego, Laura Fernández, José Azevedo, Hugo Domingos, Pedro Vieira, Amjad Parvaiz, Vladislav I Shcheslavskiy, Pedro G Silva and 1 more

Abstract read
In one paragraph

Article in Biophotonics discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

João L LagartoChampalimaud Foundation, Biophotonics Platform, Lisbon, Portugal.ORCID https://orcid.org/0000-0001-9396-8923
Alberto I HerrandoChampalimaud Foundation, Biophotonics Platform, Lisbon, Portugal.ORCID https://orcid.org/0000-0001-8380-4722
Rafaela RegoChampalimaud Foundation, Pathology Service, Biophotonics Platform, Lisbon, Portugal.ORCID https://orcid.org/0009-0006-3157-4973
Laura FernándezChampalimaud Foundation, Digestive Unit, Lisbon, Portugal.
José AzevedoChampalimaud Foundation, Digestive Unit, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-2918-3088
Hugo DomingosChampalimaud Foundation, Digestive Unit, Lisbon, Portugal.ORCID https://orcid.org/0000-0003-4161-3826
Pedro VieiraChampalimaud Foundation, Digestive Unit, Lisbon, Portugal.ORCID https://orcid.org/0000-0003-0829-0746
Amjad ParvaizChampalimaud Foundation, Digestive Unit, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-4655-1006
Vladislav I ShcheslavskiyBecker and Hickl GmbH, Berlin, Germany.ORCID https://orcid.org/0000-0003-3253-8211
Pedro G SilvaChampalimaud Foundation, Biophotonics Platform, Lisbon, Portugal.
Mireia Castillo-MartinChampalimaud Foundation, Pathology Service, Biophotonics Platform, Lisbon, Portugal.ORCID https://orcid.org/0000-0001-8926-6013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Colorectal cancer (CRC) remains one of the most frequent cancers and a leading contributor to cancer-associated mortality globally. CRCs are often diagnosed at an advanced stage, which leads to high mortality and morbidity. This outcome is exacerbated by high rates of recurrence and postoperative complications that contribute substantially to poor prognosis. Advancements in endoscopic assessment have improved CRC prevention, early detection, and surveillance over the years. Yet, CRC remains one of the most significant health challenges of the 21st century. Label-free optical spectroscopy methods have long been explored as potential partners to endoscopy, not only to enhance diagnostic accuracy but also to confer predictive capabilities to endoscopic evaluations. Aim: We investigated the potential of time-resolved autofluorescence measurements excited at 375 and 445 nm to correctly classify benign and malignant tissues in CRC surgical specimens from 117 patients. Approach: Multiparametric autofluorescence lifetime data were collected in two distinct datasets, which were used for training ( Results: Using 5-fold cross-validation, we achieved Conclusions: Although preliminary, our findings underscore the potential impact of AI-assisted autofluorescence lifetime measurements in advancing CRC prevention, early detection, and surveillance efforts.

Indexed as

autofluorescence lifetimecolorectal cancerdiagnosisdisease monitoringlabel-freemachine learningphasors

Identifiers

PMID42028250
PMCPMC13052482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.